Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Author: Benzinga Insights | February 28, 2024 09:06am

Gainers

  • vTv Therapeutics (NASDAQ:VTVT) shares increased by 104.2% to $17.36 during Wednesday's pre-market session. The market value of their outstanding shares is at $35.3 million.
  • Vivani Medical (NASDAQ:VANI) stock moved upwards by 67.32% to $1.69. The company's market cap stands at $86.2 million.
  • Genetic Technologies (NASDAQ:GENE) shares moved upwards by 17.52% to $2.28. The market value of their outstanding shares is at $8.7 million.
  • Portage Biotech (NASDAQ:PRTG) stock moved upwards by 14.28% to $0.8. The market value of their outstanding shares is at $15.8 million.
  • Ventyx Biosciences (NASDAQ:VTYX) shares moved upwards by 12.89% to $6.83. The company's market cap stands at $403.2 million. The company's, Q4 earnings came out yesterday.
  • Imunon (NASDAQ:IMNN) shares moved upwards by 12.08% to $0.8. The market value of their outstanding shares is at $7.4 million.

Losers

  • Oragenics (AMEX:OGEN) stock fell 45.3% to $1.34 during Wednesday's pre-market session. The market value of their outstanding shares is at $4.1 million.
  • Palatin Techs (AMEX:PTN) stock decreased by 34.26% to $2.61. The company's market cap stands at $42.1 million.
  • Vicarious Surgical (NYSE:RBOT) shares declined by 21.43% to $0.42. The company's market cap stands at $74.2 million.
  • ProKidney (NASDAQ:PROK) shares declined by 15.73% to $1.34. The company's market cap stands at $90.9 million.
  • Inogen (NASDAQ:INGN) shares fell 14.46% to $7.99. The market value of their outstanding shares is at $186.2 million. As per the press release, Q4 earnings came out yesterday.
  • Novavax (NASDAQ:NVAX) stock fell 13.63% to $5.2. The market value of their outstanding shares is at $617.7 million. As per the press release, Q4 earnings came out today. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: GENE IMNN INGN NVAX OGEN PROK PRTG PTN RBOT VANI VTVT VTYX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist